Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Operating expenses:
Research and development	$ 2,567,771	$ 1,319,656	$ 4,803,313	$ 2,990,518
General and administrative	1,274,803	889,453	2,892,727	1,421,051
Total operating expenses	3,842,574	2,209,109	7,696,040	4,411,569
Loss from operations	(3,842,574)	(2,209,109)	(7,696,040)	(4,411,569)
Other income:
Interest income	25,995	22,189	82,263	41,834
Total other income	25,995	22,189	82,263	41,834
Net loss	(3,816,579)	(2,186,920)	(7,613,777)	(4,369,735)
Preferred stock dividend		(288,962)		(510,240)
Net loss applicable to common stock	(3,816,579)	(2,475,882)	(7,613,777)	(4,879,975)
Other comprehensive income (loss):
Foreign currency translation adjustments	(19,208)		(39,491)
Comprehensive loss	$ (3,835,787)	$ (2,475,882)	$ (7,653,268)	$ (4,879,975)
Net loss applicable to common stock per share, basic and diluted	$ (0.20)	$ (0.56)	$ (0.40)	$ (1.11)
Weighted average common shares outstanding, basic and diluted	19,071,658	4,400,000	19,040,134	4,400,000